Are We Hitting the Target? HIV Pre-Exposure Prophylaxis from 2012 to 2020 in the OPERA Cohort.
Sign Up to like & getrecommendations! Published in 2021 at "AIDS patient care and STDs"
DOI: 10.1089/apc.2021.0064
Abstract: Preventing HIV transmission is a crucial step in ending the HIV epidemic. Safe and effective pre-exposure prophylaxis (PrEP) has been available in the United States since 2012. We set out to determine if persons at… read more here.
Keywords: prep; exposure prophylaxis; hiv; opera cohort ... See more keywords
Immunological and virological response to fostemsavir in routine US clinical care: An OPERA cohort study
Sign Up to like & getrecommendations! Published in 2024 at "HIV Medicine"
DOI: 10.1111/hiv.13700
Abstract: Fostemsavir is a novel attachment inhibitor used with other antiretrovirals in heavily treatment‐experienced (HTE) adults with multidrug‐resistant HIV‐1. Real‐world immunological and virological responses were assessed in individuals starting fostemsavir in the OPERA cohort. read more here.
Keywords: virological response; opera cohort; fostemsavir; immunological virological ... See more keywords